Lupin Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States".
Lupin Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States".